GlassScriptPhysician profile
Santos H Yu
NPI 1861474181
$22,685.85
in general payments reported to CMS, 2019-2025
84 companies · $3,114 in 2025
The $3,114 reported for 2025 was more than what 79% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,811 · 2020: $1,901 · 2021: $3,231 · 2022: $3,406 · 2023: $3,883 · 2024: $4,341 · 2025: $3,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,222.39 |
| Education | $114.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,427.72 | 2021-2025 | Ubrelvy, Botox, Qulipta |
| Biogen, INC. | $1,482.90 | 2019-2025 | Vumerity, Tysabri |
| Novartis Pharmaceuticals Corporation | $1,460.50 | 2019-2025 | |
| Ucb, INC. | $1,086.73 | 2019-2025 | Briviact, Rystiggo |
| Lundbeck LLC | $1,077.44 | 2019-2025 | Vyepti, Rexulti |
| Teva Pharmaceuticals USA, INC. | $1,043.91 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Medtronic, INC. | $839.79 | 2021-2025 | Percept PC Brainsense |
| Allergan, INC. | $758.17 | 2019-2022 | |
| Abbott Laboratories | $636.23 | 2019-2024 | Infinity, Jot Dx |
| Pfizer INC. | $603.91 | 2023-2025 | |
| Genzyme Corporation | $566.67 | 2019-2025 | |
| Neurocrine Biosciences, INC. | $563.88 | 2019-2025 | Ingrezza, Ongentys |
| Emd Serono, INC. | $520.03 | 2019-2025 | Mavenclad |
| Amgen INC. | $456.15 | 2019-2023 | Aimovig |
| Lilly USA, LLC | $446.48 | 2020-2025 | Amyvid, Kisunla, Emgality |
Show all 84 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Santos Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.